Neoadjuvant, adjuvant and palliative treatment of gastrointestinal stromal tumours (GIST) with imatinib: a centre-based study of 17 patients

Malignant gastrointestinal stromal tumours (GIST) have a poor prognosis. Since these tumours are resistant to conventional radiation and chemotherapy, surgery has been the mainstay of treatment. However, surgery is usually inadequate for the treatment of malignant GIST. Imatinib, a KIT tyrosine kina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bümming, P, Andersson, J, Meis-Kindblom, J M, Klingenstierna, H, Engström, K, Stierner, U, Wängberg, B, Jansson, S, Ahlman, H, Kindblom, L-G, Nilsson, B
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2003
Assuntos:
Clinical
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2394385/
https://ncbi.nlm.nih.gov/pubmed/12888812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600965
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados